S1P和CD69在2型糖尿病合并冠心病發(fā)病機制中的意義
[Abstract]:Objective: to investigate the possible influencing factors of coronary atherosclerotic heart disease in patients with type 2 diabetes mellitus. In particular, the expression of CD69 antigen in T lymphocytes of the mouth of bioactive lipids 1-phosphate (SIP) was associated with the risk of coronary heart disease in patients with type 2 diabetes. Methods: from October 2013 to June 2014, 68 patients with type 2 diabetes mellitus complicated with coronary heart disease (T2DM-CHD) and 81 matched non-coronary heart disease patients with type 2 diabetes mellitus (T2DM) were enrolled in this study. The expression of S1P was detected by enzyme-linked immunosorbent assay (ELISA), and the expression of CD69 antigen of CD3 CD4 T lymphocyte subsets in peripheral blood was detected by flow cytometry and immunofluorescence staining after 20 hours of stimulation with phytohemagglutinin (PHA). Biochemical and clinical information including blood glucose, blood lipids and body weight of Gao Min C reactive protein (hsCRP),) were also collected. Results the levels of S1P and ApoA1 in the peripheral blood of the group of w T2DM were significantly higher than those in the group of T2DM-CHD (P0.01), but the expression of CD69 antigen in T lymphocyte subsets of CD3 CD4 was significantly lower than that in the group of T2DM-CHD (P0.01). In the simple T2DM group, the inflammatory markers, lipid glucose index and the history of preventive therapy for coronary heart disease were significantly lower than those in the T2DM-CHD group (P0.05). At the same time, logistic regression analysis showed that S1P was an independent protective factor for type 2 diabetes mellitus, and T cell CD69 antigen hsCP2hPGL (a) was an independent risk factor for type 2 diabetic patients with coronary heart disease. Conclusion: in patients with type 2 diabetes, the decreased expression of S1P in peripheral blood and the up-regulation of CD3 CD4 CD69 T cell antigen (CD3 CD4 CD69 T cell antigen) and HsCRP are the strong driving factors of high risk of coronary heart disease in patients with type 2 diabetes. It is closely related to its occurrence and development and may be involved in its etiological pathway.
【學位授予單位】:重慶醫(yī)科大學
【學位級別】:碩士
【學位授予年份】:2015
【分類號】:R587.1;R541.4
【相似文獻】
相關期刊論文 前10條
1 錢起豐,張明霞,梁遠飛;復發(fā)性生殖器皰疹患者外周血T淋巴細胞CD69和HLA-DR的表達[J];中華皮膚科雜志;2004年05期
2 郭義龍;蔡翁義;蔡小丹;楊啟平;許敏鴻;;復發(fā)性生殖器皰疹患者外周血T細胞CD69和HLA-DR的表達[J];中國麻風皮膚病雜志;2007年08期
3 徐紅先;孫保東;肖學呂;李富榮;譚艷紅;劉冬舟;洪小平;馮小欣;蔡文虹;;γδT細胞對系統(tǒng)性紅斑狼瘡患者外周血單個核細胞凋亡和CD69表達的影響[J];實用醫(yī)學雜志;2007年02期
4 岑慧,郭蘭萍,黎東明,張衛(wèi)珍,李文,梁標;肺癌患者外周血NK細胞表達CD69的臨床意義[J];廣東醫(yī)學;2004年02期
5 吳子釗;張晨光;張婧婧;石瑛;王輝;;蝎素組分Ⅲ對Jurkat E6-1細胞中CD69表達的影響[J];現(xiàn)代預防醫(yī)學;2008年22期
6 陳鈺,劉成貴;SEB活化的人外周血T細胞CD25,CD69的表達[J];上海免疫學雜志;1998年02期
7 孫葒,曾耀英,黃柏炎,何賢輝,曾潔銘,徐麗慧;孕酮對人T淋巴細胞體外活化CD69表達的作用[J];中國免疫學雜志;2000年12期
8 賈偉;楊方;羅玲;;CD69對無痛性甲狀腺炎的診斷意義(附一例報告)[J];臨床誤診誤治;2006年08期
9 蔡陽;朱瑋;封光華;楊祺俊;冷建杭;陸貝;;胃癌圍手術期活化CD69、HLA-DR變化及臨床意義[J];醫(yī)學研究雜志;2007年02期
10 徐曉武;CD69抗原與血細胞[J];國外醫(yī)學.輸血及血液學分冊;1997年01期
相關會議論文 前2條
1 肖學呂;孫保東;譚艷紅;劉冬舟;洪小平;馮小欣;蔡文虹;徐紅先;李富榮;;γδT細胞對SLE患者外周血單個核細胞凋亡和CD69表達的影響[A];全國自身免疫性疾病專題研討會暨第十一次全國風濕病學學術年會論文匯編[C];2006年
2 肖學呂;孫保東;徐紅先;李富榮;譚艷紅;劉冬舟;洪小平;馮小欣;蔡文虹;;γδT細胞對SLE患者外周血單個核細胞凋亡和CD69表達的影響[A];第六屆中國中西醫(yī)結合風濕病學術會議論文匯編[C];2006年
相關博士學位論文 前1條
1 汪慧英;CD69在小鼠嗜酸性粒細胞中的表達及其抗體對哮喘小鼠氣道炎癥的抑制作用及機制研究[D];浙江大學;2007年
相關碩士學位論文 前1條
1 盧凡;S1P和CD69在2型糖尿病合并冠心病發(fā)病機制中的意義[D];重慶醫(yī)科大學;2015年
,本文編號:2178796
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2178796.html